Funding for this research was provided by:
Arthritis Research UK (MP/19200)
Bone Cancer Research Trust
China Scholarship Council
National Institute for Health Research
Received: 24 November 2017
Accepted: 30 April 2018
First Online: 8 May 2018
Ethics approval and consent to participate
: Samples were collected with informed written donor consent in full compliance with national and institutional ethical requirements, the United Kingdom Human Tissue Act and the Declaration of Helsinki. This study was approved by the Oxford Clinical Research Ethics Committee (C01.071). No ethical approval was required for use of the osteosarcoma cell lines.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.